Tivic Health Systems, Inc. (NASDAQ:TIVC) Sees Large Drop in Short Interest

Tivic Health Systems, Inc. (NASDAQ:TIVC) was the recipient of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 21,600 shares, a decline of 33.3% from the February 28th total of 32,400 shares. Based on an average daily trading volume, of 672,200 shares, the short-interest ratio is currently 0.0 days. Approximately 3.5% of the company’s shares are sold short.

Tivic Health Systems Trading Down 8.0 %

TIVC stock traded down $0.23 during trading on Monday, hitting $2.59. 8,220 shares of the company traded hands, compared to its average volume of 342,181. The company has a 50-day moving average of $5.18 and a 200-day moving average of $4.89. Tivic Health Systems has a 1 year low of $2.54 and a 1 year high of $31.45.

Tivic Health Systems (NASDAQ:TIVC) last released its quarterly earnings data on Friday, March 21st. The company reported ($19.68) earnings per share for the quarter, beating analysts’ consensus estimates of ($85.00) by $65.32. Tivic Health Systems had a negative return on equity of 201.30% and a negative net margin of 670.95%. During the same quarter last year, the firm earned ($176.80) earnings per share.

Tivic Health Systems Company Profile

Tivic Health Systems Inc operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S.